Navigation Links
ViroPharma To Release 2013 First Quarter Financial Results On May 1, 2013
Date:4/25/2013

EXTON, Pa., April 25, 2013 /PRNewswire/ -- ViroPharma Incorporated's (Nasdaq: VPHM) first quarter financial results for 2013 are expected to be released on Wednesday, May 1, 2013 before the open of the U.S. financial markets.

The company will host a conference call and live audio webcast at 9:00 a.m. Eastern Time on the same day.  During the conference call, ViroPharma management will discuss the 2013 first quarter financial results, review clinical data and provide development program updates along with other business.

The press release and the live webcast of the conference call will be accessible via ViroPharma's corporate website at http://www.viropharma.com.  An audio archive will be available at the same address until May 15, 2013.  To participate in the conference call, please dial (800) 874-4559 (domestic) and (302) 607-2019 (international).  After placing the call, please tell the operator you wish to join the ViroPharma investor conference call. 

About ViroPharma Incorporated 
ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet medical needs of patients living with diseases that have few if any clinical therapeutic options. ViroPharma is developing a portfolio of therapeutics for rare and Orphan diseases including C1 esterase inhibitor deficiency, cytomegalovirus (CMV), Friedreich's Ataxia, eosinophilic esophagitis (EoE) and adrenal insufficiency. Our goal is to provide rewarding careers to employees, to create new standards of care in the way serious diseases are treated, and to build international partnerships with the patients, advocates, and health care professionals we serve. ViroPharma's commercial products address diseases including hereditary angioedema (HAE), seizures in children and adolescents, adrenal insufficiency and C. difficile-associated diarrhea (CDAD). For full U.S. prescribing information on our products, please download the package inserts at http://www.viropharma.com/Products.aspx; the prescribing information for other countries can be found at www.viropharma.com

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2012 Financial Results
2. ViroPharma To Participate In Two Upcoming Healthcare Investor Conferences
3. ViroPharma Launches Novel Campaign to Illustrate the Emotional Burden of Hereditary Angioedema
4. ViroPharma Incorporated Reports Third Quarter 2012 Financial Results
5. ViroPharma To Host Analyst And Investor Seminar On September 21, 2012
6. ViroPharma to Present at the Stifel Nicolaus 2012 Healthcare Conference
7. ViroPharma Incorporated Reports Second Quarter 2012 Financial Results
8. ViroPharma To Release 2012 Second Quarter Financial Results On August 9, 2012
9. Berger & Montague, P.C. Reminds Viropharma Shareholders That The Deadline To Petition The Court To Act As Lead Plaintiff Is July 23, 2012
10. ViroPharma To Participate In The JMP Securities Healthcare Conference
11. Faruqi & Faruqi, LLP Announces Investigation of ViroPharma Incorporated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
(Date:9/12/2017)... reviews on the independent review site Consumer Affairs have ... hearing aids, ranking it higher than Miracle Ear ™, Beltone™, ... ... Aids ... that provides high performance, state-of-the-art, German-engineered hearing aids directly to consumers ...
(Date:9/7/2017)... , Sept. 7, 2017  Eli Lilly ... announced actions to streamline operations to more efficiently ... improve its cost structure. Global workforce reductions, including ... are expected to impact approximately 3,500 positions. ... company expects annualized savings of approximately $500 million ...
Breaking Medicine Technology:
(Date:9/25/2017)... ... , ... How many things are on your average daily to-do list? If ... sane human could possibly complete,” then you’re all too familiar with daily chaos. You ... be everything to everybody all the time. , Self-proclaimed overly productive person Angela Nuttle ...
(Date:9/25/2017)... ... September 25, 2017 , ... NCPDP Foundation , a ... has awarded a $40,000 grant to Johns Hopkins Medicine to address patient safety ... prescribers to electronically cancel a prescription already submitted to a pharmacy. Studies indicate ...
(Date:9/25/2017)... ... September 25, 2017 , ... International Water Advocate Sharon ... Kleyne Hour Power of Water, Global Climate Change and Your Health on VoiceAmerica ... from a once-every-four-years series of events to a personal, daily Health Olympics. “Wouldn’t ...
(Date:9/25/2017)... ... September 25, 2017 , ... Bobbie Horowitz was hardly able to walk ... issues. As a cabaret and theater producer, Horowitz would manage to get to rehearsals ... in New York City, so she had to take a cab everywhere. , ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... clinical research, today announces that 30 of its domain experts will present ... lifecycle at upcoming industry conferences and webinars. Drawing on broad and deep ...
Breaking Medicine News(10 mins):